Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-07

FDA Approved: COLESEVELAM — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original application for COLESEVELAM by Zydus Lifesciences Limited, establishing a generic form of colesevelam for cholesterol management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam (colesevelam)

Snippet

ORIG AP for COLESEVELAM (COLESEVELAM)